Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,761 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00385775 | Study of XIAP Antisense for Advanced Cancers | terminated | Phase 1 | 30 | Aegera TherapeuticsINDUSTRY | 1 | Aug 21, 2008 | clinicaltrials |
| NCT00159328 |
| Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids |
| completed |
| Phase 4 |
| 50 |
| Imperial College LondonOTHER |
| 1 |
| Aug 13, 2008 |
| clinicaltrials |
| NCT00145015 | FishGastro Study: Fish Consumption and Gastro-Intestinal Health | completed | N/A | 270 | Quadram Institute BioscienceOTHER | 2 | Jul 30, 2008 | clinicaltrials |
| NCT00718250 | Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2(RFUSIN2-AML1) | unknown | Phase 1 | 24 | King's College Hospital NHS TrustOTHER | 1 | Jul 18, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00298688 | A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 56 | AstraZenecaINDUSTRY | 2 | Jun 12, 2008 | clinicaltrials |
| NCT00693290 | Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy | unknown | N/A | 100 | University of UlsterOTHER | 1 | Jun 9, 2008 | clinicaltrials |
| NCT00635063 | A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects | terminated | Phase 3 | 150 | SoseiINDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation(RAPTURE) | completed | Phase 2 | 106 | Angiodynamics, Inc.INDUSTRY | 5 | Jun 5, 2008 | clinicaltrials |
| NCT00683969 | A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis | completed | Phase 3 | 136 | Hoffmann-La RocheINDUSTRY | 14 | May 26, 2008 | clinicaltrials |
| NCT00490789 | Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM(TESSTAL) | unknown | Phase 2 | 14 | Cardiff UniversityOTHER | 1 | Apr 30, 2008 | clinicaltrials |
| NCT00656227 | A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision | unknown | Phase 2 | 239 | RenovoINDUSTRY | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00087503 | Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | completed | Phase 2 | 28 | PfizerINDUSTRY | 5 | Apr 1, 2008 | clinicaltrials |
| NCT00050999 | Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients | completed | Phase 4 | 195 | Eisai Inc.INDUSTRY | 10 | Mar 5, 2008 | clinicaltrials |
| NCT00051012 | Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients | completed | Phase 4 | 86 | Eisai Inc.INDUSTRY | 9 | Mar 5, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 | clinicaltrials |
| NCT00571363 | A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma | completed | N/A | 30 | NHS TaysideOTHER_GOV | 1 | Dec 12, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00313755 | Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance | completed | N/A | 60 | London North West Healthcare NHS TrustOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00551044 | Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer | completed | N/A | 42 | Wirral University Teaching Hospital NHS TrustOTHER | 1 | Oct 30, 2007 | clinicaltrials |
| NCT00536653 | Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer | completed | N/A | 618 | Wirral University Teaching Hospital NHS TrustOTHER | 1 | Sep 28, 2007 | clinicaltrials |
| NCT00237276 | Experience and Enhancement: Improving Colonoscopic Polyp Detection | unknown | N/A | 30 | London North West Healthcare NHS TrustOTHER | 1 | Sep 24, 2007 | clinicaltrials |
| NCT00253812 | Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy | unknown | N/A | 60 | London North West Healthcare NHS TrustOTHER | 1 | Sep 24, 2007 | clinicaltrials |
| NCT00520052 | Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer | completed | N/A | 58 | Wirral University Teaching Hospital NHS TrustOTHER | 1 | Aug 23, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00279357 | Randomised Trial of NBI for Adenoma Detection | unknown | N/A | 214 | London North West Healthcare NHS TrustOTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00065533 | Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer | completed | Phase 2 | 92 | Eli Lilly and CompanyINDUSTRY | 6 | Jun 22, 2007 | clinicaltrials |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy | completed | Phase 2 | 91 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 22, 2007 | clinicaltrials |
| NCT00191438 | Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents | completed | Phase 3 | 300 | Eli Lilly and CompanyINDUSTRY | 6 | May 28, 2007 | clinicaltrials |
| NCT00109096 | Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 4 | May 17, 2007 | clinicaltrials |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | completed | Phase 2 | 168 | PfizerINDUSTRY | 9 | May 4, 2007 | clinicaltrials |
| NCT00463359 | A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base | unknown | N/A | 50 | University of GlasgowOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00462189 | Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease | unknown | Phase 1 | 40 | Cambridge Antibody TechnologyOTHER | 3 | Apr 18, 2007 | clinicaltrials |
| NCT00099281 | DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | terminated | Phase 3 | 700 | YM BioSciencesINDUSTRY | 1 | Feb 28, 2007 | clinicaltrials |
| NCT00289003 | The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients | completed | Phase 2 | 40 | Biotec Pharmacon ASAINDUSTRY | 2 | Jan 17, 2007 | clinicaltrials |
| NCT00422526 | Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial | completed | Phase 3 | 250 | King's College Hospital NHS TrustOTHER | 4 | Jan 17, 2007 | clinicaltrials |
| NCT00050830 | A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 163 | PfizerINDUSTRY | 8 | Nov 8, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00180830 | Glivec Phase II Pediatric Study | terminated | Phase 2 | 36 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Sep 11, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
| NCT00346281 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | unknown | Phase 2 | 15 | pSiMedica LimitedINDUSTRY | 2 | Jun 29, 2006 | clinicaltrials |
| NCT00323505 | A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | May 9, 2006 | clinicaltrials |
| NCT00276029 | TNF Alpha in Refractory Asthma | completed | N/A | 10 | University Hospitals, LeicesterOTHER | 1 | May 4, 2006 | clinicaltrials |
| NCT00301275 | Assessing Free Immunoglobulin Light Chains in Patients With Myeloma | completed | — | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 10, 2006 | clinicaltrials |
| NCT00073502 | Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer | completed | Phase 2 | 43 | OSI PharmaceuticalsINDUSTRY | 3 | Feb 22, 2006 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials